Gilead (GILD) stock won an upgrade from Deutsche Bank on HIV treatment boost, while Merck (MRK) stock received a downgrade on ...

Deutsche Bank is to change the leadership of its investment bank as it enters a decisive year in the execution of its ...

Mark Fedorcik, Co-Leiter der Investmentbank der Deutschen Bank, wird sich nach 30-jähriger Tätigkeit für das Frankfurter ...

Deutsche Bank (DB) has undertaken a three-year hiring spree that nearly completely reversed the steep job cuts imposed by CEO Christain Sewing ...

Deutsche Bank analyst Lars Vom Cleff maintained a Buy rating on SGL Carbon (0MPL – Research Report) today and set a price target of €7.40. The ...

Deutsche appears to have completed its hiring push. Last September, it even added a layer of management with the appointment of Basile Benoit and Tobias Wagnert to the newly created roles of co-heads ...

Fintel reports that on February 18, 2025, Deutsche Bank upgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from Hold ...

In a report released today, Robert Sanders MBA from Deutsche Bank maintained a Buy rating on ams-OSRAM (AUKUF – Research Report), with a price ...

Deutsche Bank upgraded Gilead (GILD) to Buy from Hold with a $120 price target Discover the Best Stocks and Maximize Your Portfolio: See what ...

Deutsche Bank upgraded Gilead (GILD) to Buy from Hold with a price target of $120, up from $80. The company’s core HIV treatment franchise ...

The Delhi High Court on Friday extended the interim bail granted to Jaideep Sengar, brother of expelled BJP leader Kuldeep Sengar, till March 11 on medical grounds. Jaideep, who is serving 10-year ...

Top-seeded Gill St. Bernard’s used a strong fourth quarter to close out a 56-45 win over fourth-seeded Ridge in the semifinal round of the Somerset County Tournament. Gill St. Bernard’s (19-4 ...